Overall rank by patents
#13,641
of 50,000 tracked assignees
USPTO PatentsView assignee record - 22 granted patents across 7 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
According to USPTO PatentsView, Qiagen ranks #13,641 of 50,000 tracked US assignees by granted-patent volume, with 22 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R13641 · US Corporation #13,641 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Prove Identity, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Qiagen Gaithersburg · this assignee
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Qiagen Gaithersburg Inc. stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-RICH, TYPE-USCORP, VEL-DROP, BOOK-FULL. Volume places it #13,641 of 50,000; Innovation Score 31.3/100 sits in the top 63% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Prove Identity, Inc. (±0 grants).
Qiagen Gaithersburg Inc. has been granted 22 US utility patents between 2015 and 2018, placing Qiagen Gaithersburg Inc. at #13,641 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Qiagen Gaithersburg Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Qiagen sits between Prove Identity, Inc. (22 patents, rank #13,633) and Quantum Valley Investment Fund Lp (22 patents, rank #13,641) - the closest US assignees by grant volume. The composite Innovation Score of 31.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 0 grants, compared with 22 in the 2015–2019 window, a -100% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Qiagen Gaithersburg Inc.'s 18.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 7 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Prove Identity, Inc.
22 patents
Provincial Health Services Authority
22 patents
Provivi, Inc.
22 patents
Q.E.D. Environmental Systems, Inc.
22 patents
QUIXOTIC HOLDINGS, LLC
22 patents
Quality Vision International Inc.
22 patents
QuantaEd, LLC
22 patents
Quantum Valley Investment Fund LP
22 patents
QIAGEN GAITHERSBURG INC.
22 patents
What this shows Qiagen holds 22 patents at rank #13,637, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,637 in granted patent volume.
Other assignees with the most granted patents in Qiagen's primary technology class.
Qiagen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 63% higher than 37% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 36.4% |
| 2016 | 7 | 31.8% |
| 2017 | 5 | 22.7% |
| 2018 | 2 | 9.1% |
Top 7 of 7 technology areas
Overall rank by patents
#13,641
of 50,000 tracked assignees
31.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.